CIPHER PHARMACEUTICALS INC/ CA17253X1050 /
| 2024-08-02 10:00:00 PM | Chg. -0.21 | Volume | Bid10:11:00 PM | Ask10:11:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 12.13CAD | -1.70% | 28,586 Turnover: 334,656.50 |
12.10Bid Size: 100 | 12.67Ask Size: 200 | 12.37 | 12.00 |
Newsfile Corp
04-03
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Co...
Newsfile Corp
2023-04-18
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire
2021-08-12
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Cran...
GlobeNewswire
2019-08-08
Aclaris Therapeutics Reports Second Quarter 2019 Financial Results, Provides Business Strategy Updat...
GlobeNewswire
2019-03-18
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update...
GlobeNewswire
2018-07-20
HSR Act Waiting Period Terminated for United Therapeutics’ Acquisition of SteadyMed Ltd.
GlobeNewswire
2018-05-08
Aclaris Therapeutics Reports First Quarter 2018 Financial Results and Provides Update on Clinical an...
GlobeNewswire
2018-04-06
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercial...
GlobeNewswire
2018-03-30
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
